Skip to main content
JIN YANG PHARMACEUTICAL. CO., LTD logo

JIN YANG PHARMACEUTICAL. CO., LTD — Investor Relations & Filings

Ticker · 007370 ISIN · KR7007370000 KO Manufacturing
Open in API
Filings indexed 210 across all filing types
Latest filing 2020-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 007370

About JIN YANG PHARMACEUTICAL. CO., LTD

https://www.jinyangpharm.com/

JIN YANG PHARMACEUTICAL. CO., LTD. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products, with a primary focus on prescription drugs. The company operates a fully automated, high-tech manufacturing facility. Its research and development efforts are dedicated to creating advanced preventive and therapeutic treatments for various diseases. Key areas of R&D include the development of anticancer drugs through molecular biology research, particularly for leukemia, and therapies for metabolic disorders such as diabetes and obesity. The company also develops antivirals and explores formulations based on herbal preparations.

Recent filings

Filing Released Lang Actions
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Jinyang Pharmaceutical for the period 2020.01.01 to 2020.03.31. It contains detailed financial data, business operations, production capacity, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-15 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Jinyang Pharmaceutical regarding the extension of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 연장결정). This filing details the terms of the share repurchase program, including contract dates, financial limits, and board resolutions. Under the provided definitions, documents detailing the company's buyback or issuance of its own shares are classified as 'Transaction in Own Shares' (POS).
2020-04-09 Korean
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Jinyang Pharmaceutical Co., Ltd. for the fiscal year 2019 (2019.01.01-2019.12.31). It contains comprehensive company information, including business overview, financial data, shareholding structure, and management details. In the context of Korean regulatory filings (DART), a 'Business Report' (사업보고서) is the equivalent of an Annual Report (10-K). FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Regular General Meeting of Shareholders Results) and provides the official outcomes of the meeting held on 2020-03-20, including the approval of financial statements, dividend declarations, and board/auditor compensation. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2020-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Jinyang Pharmaceutical. It provides a summary of the audit opinion (unqualified/appropriate) and key financial data (assets, liabilities, profit/loss) for the fiscal year. According to the 'Menu vs Meal' rule, this is a short regulatory announcement (under 5,000 characters) notifying the market that the audit report has been submitted/received, rather than the full audit report document itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2019
2020-03-12 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Audit Report / Information Classification · 95% confidence The document is a regulatory filing from a Korean company (JinYang Pharm) regarding a correction to a previously disclosed financial statement (specifically, a change in revenue or profit structure exceeding 15%). It details the specific line items that were corrected (operating profit, net income, etc.) and provides the updated financial figures. This type of filing is a standard regulatory disclosure in the Korean market (DART system) for material financial changes, which falls under the 'Regulatory Filings' category as it is a specific corporate disclosure update. FY 2019
2020-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.